122 related articles for article (PubMed ID: 28747748)
1. The Epigenetic Landscape of Promoter Genome-wide Analysis in Breast Cancer.
Karsli-Ceppioglu S; Dagdemir A; Judes G; Lebert A; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Sci Rep; 2017 Jul; 7(1):6597. PubMed ID: 28747748
[TBL] [Abstract][Full Text] [Related]
2. H3K4 acetylation, H3K9 acetylation and H3K27 methylation in breast tumor molecular subtypes.
Judes G; Dagdemir A; Karsli-Ceppioglu S; Lebert A; Echegut M; Ngollo M; Bignon YJ; Penault-Llorca F; Bernard-Gallon D
Epigenomics; 2016 Jul; 8(7):909-24. PubMed ID: 27424567
[TBL] [Abstract][Full Text] [Related]
3. Comparative epigenetic analyses reveal distinct patterns of oncogenic pathways activation in breast cancer subtypes.
Li Y; Li S; Chen J; Shao T; Jiang C; Wang Y; Chen H; Xu J; Li X
Hum Mol Genet; 2014 Oct; 23(20):5378-93. PubMed ID: 24871326
[TBL] [Abstract][Full Text] [Related]
4. Analysis of H3K4me3 and H3K27me3 bivalent promotors in HER2+ breast cancer cell lines reveals variations depending on estrogen receptor status and significantly correlates with gene expression.
Kaukonen D; Kaukonen R; Polit L; Hennessy BT; Lund R; Madden SF
BMC Med Genomics; 2020 Jul; 13(1):92. PubMed ID: 32620123
[TBL] [Abstract][Full Text] [Related]
5. A novel subtype classification and risk of breast cancer by histone modification profiling.
Chen X; Hu H; He L; Yu X; Liu X; Zhong R; Shu M
Breast Cancer Res Treat; 2016 Jun; 157(2):267-279. PubMed ID: 27178334
[TBL] [Abstract][Full Text] [Related]
6. Histone H3 lysine 4 acetylation and methylation dynamics define breast cancer subtypes.
Messier TL; Gordon JA; Boyd JR; Tye CE; Browne G; Stein JL; Lian JB; Stein GS
Oncotarget; 2016 Feb; 7(5):5094-109. PubMed ID: 26783963
[TBL] [Abstract][Full Text] [Related]
7. Global analysis of H3K27me3 as an epigenetic marker in prostate cancer progression.
Ngollo M; Lebert A; Daures M; Judes G; Rifai K; Dubois L; Kemeny JL; Penault-Llorca F; Bignon YJ; Guy L; Bernard-Gallon D
BMC Cancer; 2017 Apr; 17(1):261. PubMed ID: 28403887
[TBL] [Abstract][Full Text] [Related]
8. Oncofetal Epigenetic Bivalency in Breast Cancer Cells: H3K4 and H3K27 Tri-Methylation as a Biomarker for Phenotypic Plasticity.
Messier TL; Boyd JR; Gordon JA; Stein JL; Lian JB; Stein GS
J Cell Physiol; 2016 Nov; 231(11):2474-81. PubMed ID: 26916849
[TBL] [Abstract][Full Text] [Related]
9. Combinatorial epigenetic regulation of non-coding RNAs has profound effects on oncogenic pathways in breast cancer subtypes.
Xu J; Wang Z; Li S; Chen J; Zhang J; Jiang C; Zhao Z; Li J; Li Y; Li X
Brief Bioinform; 2018 Jan; 19(1):52-64. PubMed ID: 27742663
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
Kar S; Patra SK
Gene; 2018 Feb; 643():35-45. PubMed ID: 29203199
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic Modifications with DZNep, NaBu and SAHA in Luminal and Mesenchymal-like Breast Cancer Subtype Cells.
Dagdemir A; Judes G; Lebert A; Echegut M; Karsli-Ceppioglu S; Rifaï K; Daures M; Ngollo M; Dubois L; Penault-Llorca F; Bignon YJ; Bernard-Gallon D
Cancer Genomics Proteomics; 2016; 13(4):291-303. PubMed ID: 27365379
[TBL] [Abstract][Full Text] [Related]
12. SILAC-based proteomic analysis to dissect the "histone modification signature" of human breast cancer cells.
Cuomo A; Moretti S; Minucci S; Bonaldi T
Amino Acids; 2011 Jul; 41(2):387-99. PubMed ID: 20617350
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer.
Kagara N; Huynh KT; Kuo C; Okano H; Sim MS; Elashoff D; Chong K; Giuliano AE; Hoon DS
Am J Pathol; 2012 Jul; 181(1):257-67. PubMed ID: 22626806
[TBL] [Abstract][Full Text] [Related]
14. Global histone modification profiling reveals the epigenomic dynamics during malignant transformation in a four-stage breast cancer model.
Zhao QY; Lei PJ; Zhang X; Zheng JY; Wang HY; Zhao J; Li YM; Ye M; Li L; Wei G; Wu M
Clin Epigenetics; 2016; 8():34. PubMed ID: 27034728
[TBL] [Abstract][Full Text] [Related]
15. Towards sustained silencing of HER2/neu in cancer by epigenetic editing.
Falahi F; Huisman C; Kazemier HG; van der Vlies P; Kok K; Hospers GA; Rots MG
Mol Cancer Res; 2013 Sep; 11(9):1029-39. PubMed ID: 23814024
[TBL] [Abstract][Full Text] [Related]
16. DNA methylation and not H3K4 trimethylation dictates the expression status of miR-152 gene which inhibits migration of breast cancer cells via DNMT1/CDH1 loop.
Sengupta D; Deb M; Rath SK; Kar S; Parbin S; Pradhan N; Patra SK
Exp Cell Res; 2016 Aug; 346(2):176-87. PubMed ID: 27475839
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of GATA4 expression by histone modification in AFP-producing gastric adenocarcinoma.
Yamamura N; Kishimoto T
Exp Mol Pathol; 2012 Aug; 93(1):35-9. PubMed ID: 22472323
[TBL] [Abstract][Full Text] [Related]
18. The Role of Dietary Extra Virgin Olive Oil and Corn Oil on the Alteration of Epigenetic Patterns in the Rat DMBA-Induced Breast Cancer Model.
Rodríguez-Miguel C; Moral R; Escrich R; Vela E; Solanas M; Escrich E
PLoS One; 2015; 10(9):e0138980. PubMed ID: 26401660
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic modifications, chromatin distribution and TP53 transcription in a model of breast cancer progression.
Santos GC; da Silva AP; Feldman L; Ventura GM; Vassetzky Y; de Moura Gallo CV
J Cell Biochem; 2015 Apr; 116(4):533-41. PubMed ID: 25358520
[TBL] [Abstract][Full Text] [Related]
20. The dual role of FOXF2 in regulation of DNA replication and the epithelial-mesenchymal transition in breast cancer progression.
Lo PK; Lee JS; Liang X; Sukumar S
Cell Signal; 2016 Oct; 28(10):1502-19. PubMed ID: 27377963
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
